Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.040
-0.020 (-1.89%)
At close: Apr 28, 2026, 4:00 PM EDT
1.097
+0.057 (5.46%)
After-hours: Apr 28, 2026, 7:38 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $196.22 million as of April 28, 2026. Its market cap has increased by 57.99% in one year.
Market Cap
196.22M
Enterprise Value
190.12M
1-Year Change
57.99%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $196.22M, a decrease of -61.84%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 199.99M | 39.95% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 277.59M |
| Profound Medical | 253.63M |
| 908 Devices | 249.32M |
| Sight Sciences | 234.39M |
| Electromed | 218.96M |
| InfuSystem Holdings | 218.50M |
| CVRx, Inc. | 206.95M |
| Inogen | 197.15M |